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Abstract:  Photorhabdus luminescens is a nematode-symbiotic, gram negative, 
bioluminescent bacterium, belonging to the family of Enterobacteriaceae. Recent studies 
show the importance of this bacterium as an alternative source of insecticides, as well as an 
emerging human pathogen. Various toxins have been identified and characterized in this 
bacterium. These toxins are classified into four major groups: the toxin complexes (Tcs), 
the Photorhabdus insect related (Pir) proteins, the “makes caterpillars floppy” (Mcf) toxins 
and the Photorhabdus virulence cassettes (PVC); the mechanisms however of toxin 
secretion are not fully elucidated. Using bioinformatics analysis and comparison against 
the components of known secretion systems, multiple copies of components of all known 
secretion systems, except the ones composing a type IV secretion system, were identified 
throughout the entire genome of the bacterium. This indicates that Photorhabdus 
luminescens has all the necessary means for the secretion of virulence factors, thus it is 
capable of establishing a microbial infection. 
Keywords:  Photorhabdus luminescens;  bacterial protein toxins; secretion systems;   
gram-negative bacteria 
 
1. Introduction  
Photorhabdus luminescens is a nematode-symbiotic, gram negative, bioluminescent bacterium, 
belonging to the family of Enterobacteriaceae. It is part of the Photorhadbus genus, known to have 
three bacterial species: Photorhabdus luminescens,  Photorhabdus temperata and Photorhabdus 
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asymbiotica [1]. The first two species are nematode-symbiotic, while the third one has been isolated 
from human wounds, suggesting a role of this bacterium as an emerging human pathogen. 
P. luminescens has a complex life cycle. It is symbiotic to entomopathogenic nematodes of the 
family Heterorhabditidiae [1,2], colonizing in the intestine. Heterorhabditis attacks insects at the stage 
of larvae. Once the nematode, in its infective juvenile stage, enters the bloodstream of the target insect, 
the bacteria are released and secrete toxins that rapidly kill the insect. Enzymes are also produced from 
the bacteria that lead to the decomposition of the carcass, providing both the bacteria and the 
nematodes with enough food for survival and reproduction. Then, new infective juveniles colonized 
with the bacterium grow, before emerging from the carcass into the soil. Bactericidal products of  
P. luminescens prevent infections of the carcass by other bacteria.  
In order to combine symbiosis with the nematode and pathogenicity with the larva of the insect,  
P. luminescens must produce factors that can do both. The pathogenicity of the bacterium is the result 
of the presence of pathogenicity islands on its chromosome. In these islands there is a large number of 
genes that encode for toxins, enzymes, bacteriocins and antibiotics. Secretion of these proteins may 
happen with the use of different secretion systems, such as the type III secretion system. Genomic 
islands also encode for genes that are responsible for symbiosis and nematode growth.  
Another characteristic of P. luminescens is that it undergoes phase variation [1,3]. There are two 
phenotypic variants of the bacterium. Phase I or primary variant is found at the infective juvenile stage 
of the nematode life cycle. At this point, the bacterium produces dyes, antibiotics, lipases, proteases 
and bioluminescence (due to the lux operon). Phase II or secondary variants are the result of in vitro 
cultures, after extended incubation, probably as a response to environmental stress. These variants lack 
or have reduced levels of the properties of the phase I variants. However, both of the variants show 
similarities to their pathogenicity. 
P. luminescens produces a number of toxins. Tc toxins [4] are a new class of insecticidal toxins that 
have been shown to demonstrate both oral and injectable activity with results against the Colorado 
potato beetle, Leptinotarsa decemlineata and Bemisia tabaci [5], while other toxins like Mcf promote 
apoptosis in a variety of cells including mammalian ones. This states the potential use of the   
P. luminescens toxins as a replacement of the Bt  toxins (Bacillus thuringiensis toxins) in the 
agriculture of transgenic crops infected by insects resistant to Bt toxins [6]. On the other hand, the fact 
that human infections with Photorhabdus species have been stated before in the USA and Australia 
[7,8], and the similarity of the tc genes of P. luminescens with its corresponding genes from Yersinia 
pestis [9], the causative agent of plague, can raise some serious questions on the possibility of a new 
human pathogen emerging. 
2. Toxins of Photorhabdus luminescens 
In order to be able to infect its host and survive, P. luminescens must be capable of producing a 
wide range of proteins, including toxins. The complete genomic analysis of this organism has revealed 
that it indeed possesses a lot of genes encoding for toxins, proteases and lipases [10]. Four 
pathogenicity islands were also identified in the P. luminescens genome [11,12]; three of them contain 
genes that encode for toxins, while the last one encodes for a type III secretion system. Toxins 2010, 2                        
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In P. luminescens, toxins are classified into four major groups: the toxin complexes (Tcs) with a 
high similarity to the ones found in Y. pestis genome [9], the Photorhabdus insect related (Pir) 
proteins, the “makes caterpillars floppy” (Mcf) toxins and the Photorhabdus virulence cassettes   
(PVC) [6,13]. 
2.1. Toxin Complexes (Tcs) 
The toxin complexes (Tcs) are encoded by the PAI I (pathogenicity island I) [11,12] and have been 
identified as high molecular weight insecticidal toxins comprised of multiple subunits [4,6,14]. There 
are four such complexes, namely Tca, Tcb, Tcc and Tcd, found in different loci. However, tca and  
tcc loci encode for several open reading frames (ORFs) [14–16], thus producing multiple components 
per locus; tcb  and  tcd are comprised of a single long ORF. Tca, Tcb and Tcc show no overall 
similarities with other sequences in GenBank; however TccA (one of the three different ORFs of the 
tcc  locus) shows similarity to a Salmonella protein (SpvA), while TcaC shows similarity to   
SpvB [16,17].  
The three complexes show significant similarity to one another; therefore three basic types of 
genetic elements have been identified: the tcdA-like element, equivalent to the combination of tcaA 
and tcaB, the tcdB-like element, equivalent to the tcaC and the tccC-like element. tcdA-like elements 
are responsible for establishing primary toxicity, while the tcdB/tccC-like elements are potentially  
toxic [18]. Genomic analysis of P. luminescens W14 has also revealed the presence of cytolytic   
RTX-like toxins, similar to those secreted by the two-partner system of Vibrio cholerae (RtxA-RtxB), 
Serratia marcescens (ShA-ShB), Erwinia tarda (EthA-EthB) and Erwinia chrysanthemi  
(HecA-HecB), as well as the presence of novel tc loci, based on homology and BLAST search [19]. 
tcb and tcd loci encode for proteins of similar sizes as the A and B toxins of Clostridium difficile, 
suggesting similar modes of action between the proteins of the two loci and the ones of the 
Clostridium  [17].  tca and tcd encode for orally active toxins, responsible for the majority of the 
insecticidal activity in Manduca secta [20].  
The tc genes are encoded alongside other genes with putative virulence functions [13,21]. Tc-like 
genes have been identified in both other insect-associated bacteria such as Serratia entomophila and 
non-insect-associated bacteria like some Pseudomonas species [4,6]. The insecticidal activity of these 
complexes is of proteinaceous nature and toxicity is achieved through oral administration [15,17]. 
2.2. Photorhabdus Insect Related (Pir) Toxins 
The Photorhabdus insect related (Pir) toxins act as binary proteins. They are encoded by the PirAB 
genes, located at plu4093-4092 (pirA) and plu4437-4436 (pirB) loci of P. luminescens TT01 genome; 
both proteins are necessary for injectable but not oral activity [6,13]. These proteins show similarities 
to the δ-endotoxins of Bacillus thuringiensis, thus making them a putative substitute for Bt (Bacillus 
thuringiensis toxin) recombinant crops [6]. PirA shows little similarity to known proteins, but its 
partner PirB shows high homology with the N-terminal region of the pore-forming domain of the 
Cry2A insecticidal toxin, suggestive of the existence of a similar motif in these binary proteins. PirB 
also has similarities with a developmentally regulated protein from the beetle Leptinotarsa 
decemlineata; this beetle protein is presumed to have a juvenile hormone esterase (JHE) activity due to Toxins 2010, 2                        
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the relation of its expression profile during insect development and the levels of juvenile hormone (JH) 
produced, thus leading to the assumption that PirB may display the same kind of activity. However, 
such activity is not demonstrated by PirB [22,23].  
Within the DNA sequences of the encoding genes, enterobacterial repetitive intergenic consensus 
(ERIC) sequences have been identified [11,24], suggested to be important for mRNA stability. 
2.3. “Makes Caterpillars Floppy” Toxins 
The “makes caterpillars floppy” toxins 1 (Mcf1) and 2 (Mcf2) act upon injection [6,13,25] and they 
are encoded by PAI II [11,12], along with other hemagglutinin-like proteins. Mcf1 has been shown to 
promote apoptosis in the midgut, producing a characteristic “floppy” phenotype in the infected insect, 
as well as in mammalian cells [26]; it mimics BH3 domain proteins that are found in mitochondria and 
have proapototic actions [13] as in its N-terminal domain, this protein has a Bcl2-homology 3-like 
domain (BH3 domain). Its central domain is of hydrophobic character with high similarity of the 
translocation domain of the Clostridium difficile toxin B, while the C-terminal domain of Mcf1 resembles 
the repeats-in toxin (RTX) like toxins of another bacterium (Actinobacillus pleuropneumoniae)  
(Figure 1) [26].  
Figure 1. The domain structures of the Mcf proteins. Mcf1 is longer than Mcf2 and in its 
N-terminus it carries a BH3-like motif, suggestive of its proapoptotic function. In the 
middle, it has a Cytotoxin B-like motif, highly similar to Clostridium cytotoxin B, while in 
its C-tereminus there is a RTX-like domain. In Mcf2, that RTX-like motif is not found in 
the C-terminus of the protein. Mcf2 also has a region similar to Clostridium cytotoxin 
B,but it also possesses another domain, similar to HrmA protein (a protein secreted by a 
type III secretion system) in its N-terminus. Adapted from Dowling et al. [26] and 
Waterfield et al. [27]. 
 
Mcf2 N-terminus shows similarity to a type III secreted protein of a plant pathogen (Pseudomonas 
syringae) but it lacks the BH3-like domain (Figure 1) [27]. mcf2 locus is located next to a type I 
secretion system operon.  
Both Mcf1 and Mcf2 have C-terminal domains that support their export via a type I secretion 
system [23]. These toxins, when expressed recombinantly in Escherichia coli, allow the bacterium to 
survive inside the insect and promote its death and they have been possibly evolved to provide the Toxins 2010, 2                        
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bacterium with toxicity against different kinds of insects. A different site of action within the insect is 
also possible for the existence of two different proteins with the same properties [27]. 
2.4. Photorhabdus Virulence Cassettes (PVC) 
Given the fact that plenty other toxins should be encoded by the P. luminescens genome, in order to 
make it more efficient in its survival, another group of putative toxins has been identified through 
homology to antifeeding genes in Serratia entomophila [6,13]. These genes in Serratia are encoded in 
a plasmid carrying tc homologues and are located in a locus encoding proteins of high similarity to 
phage proteins [28,29].  
In  P. luminescens, multiple copies of those genes have been recognized and are known as 
“Photorhabdus virulence cassettes” (PVCs). These genes show sequence similarities to known toxins 
such as the Mcf of P. luminescens or the toxin A of C. difficile [6]. Each of these cassettes encodes for 
15-20 proteins, about 30nm wide, that resemble R-type pyocins, a type of bacteriocin. The protein 
products of the PVCs have no direct antibacterial activity, but do destruct insect hemocytes.. These 
proteins also show similarities to phage tail and base plate assembly proteins, fimbrial usher and 
proteins from other pathogenic bacteria [13]. Their loci can be found clustered between a type IV 
conjugation pilus and the mukB locus, a locus involved in plasmid stability. Furthermore, their effector 
proteins are located always downstream of the PVCs and are flanked by transposon sequences, 
indicative of a possible mechanism of insertion in the PVC or even their movement among different 
PVCs [13]. 
3. Secretion Systems and Photorhabdus luminescens 
Bacteria depend upon their communication with the extracellular environment for survival and 
interaction with other cells. As such, proteins that are synthesized in the cytoplasm must be transferred 
to the extracellular space (protein secretion). However, bacterial cells are surrounded by a cell 
envelope that includes the cell (cytoplasmic) membrane and a cell wall, surrounding it. In Gram 
negative bacteria, protein secretion involves the crossing of the newly-synthesized protein through two 
sets of membrane, the inner membrane (IM) and the outer membrane (OM), as well as the space 
spanning between them, namely the periplasmic space, leading to the development of elaborate 
secretion mechanisms [30,31]. 
Secretion can be performed in one or two steps, dividing the secretion pathways in two categories:  
(i) one-step or Sec-independent pathways, where the protein is secreted through a channel spanning 
both membranes and the periplasm and (ii) two-step or Sec-dependent pathways, where the protein is 
initially transferred into the periplasm across the IM with the help of a protein complex embedded in it 
(Sec translocase), then crosses the periplasm and subsequently is transferred through the OM into the 
extracellular environment. Up to date, at least seven types of protein secretion pathways have been 
recognized in Gram-negative bacteria. Toxins 2010, 2                        
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3.1. One Step Secretion Systems 
3.1.1. Type I Secretion System 
The type I system is a Sec-independent secretion pathway comprised of three membrane proteins: 
an ABC (ATP-binding cassette) protein located in the IM that provides the necessary energy amount 
for secretion and is characterized by conserved regions called Walker A and Walker B motifs, a   
TolC-like OM channel protein used for the protein export and a membrane fusion protein (MFP) that 
connects the IM and OM components of the secretion apparatus [32,33]. 
The genes encoding type I substrates and its components are typically found in the same operon, 
although there are cases where the components can be found in distant positions on the chromosome. 
The type I secretion system has been studied extensively in E. coli [33,34]. In this case, TolC is 
recruited by the binding of the substrate (HlyA) to the IM complex. The MFP component (HlyD) joins 
the cytoplasmic and the periplasmic tunnel that causes an allosteric change. This allows the channel of 
the TolC to open and release the substrate. Once the transfer is completed, the complex disengages and 
TolC returns to its closed state. 
Bioinformatics analysis in the P. luminescens laumondii TT01 genome has revealed that this 
bacterium possesses multiple copies of this system. More specifically, six putative type I systems  
(Table 1) were identified. The ABC and MFP proteins are present in all six systems, with three TolC 
homologues. All ABC and MFP genes are located adjacent to one another and have the nucleotide-
binding Walker A and Walker B motifs [35], proving the ATP used by these systems. 
3.1.2. Type III Secretion System 
Type III secretion system has the unique ability of transporting its effectors directly into the host 
cell cytosol, by forming a needle-like structure. The apparatus itself is composed of 20–25 [36,37] 
proteins that are highly conserved. Most of the type III secretion system components are homologous 
to the ones implicated in the flagellar biosynthesis [37]. 
The apparatus is comprised of structures on the bacterial surface, an inner membrane ring and an 
OM ring [36]. Needle-like structures have been identified in Yersinia species, which type III secretion 
system is used as a prototype of that kind of secretion mechanism (ysc gene cluster), Salmonella, 
Shigella and Escherichia [38,39]. 
Phylogenetic analysis of the species known to carry type III secretion system genes has revealed 
seven different families of type III secretion systems, each one of them presenting highly conserved 
genes and cluster organization. P. luminescens type III secretion system has been identified and it is 
categorized in the same family as the Ysc type III secretion system of Yersinia species. In the same 
family belong the type III systems of Pseudomonas aeruginosa, Aeromonas species,   
Vibrio parahaemolyticus, Bordetella species and Desulfovibrio vulgaris [39]. Two type III secretion 
systems were revealed for the Photorhabdus luminescens: the Sct type III secretion system and a type 
III flagellar assembly system system (Supplementary Table 1). A genomic comparison between   
P. luminescens and the emerging human pathogen P. asymbiotica shows that the latter possesses a 
third type III secretion system, which is however located in a second type III secretion system island  
(in P. luminescens genome, there is only one type III secretion system encoding operon, the effector Toxins 2010, 2                        
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proteins of which facilitate inhibition of phagocytosis of the bacterium by hemocytes) [23]. The 
acquisition of the second type III secretion system island, which resembles the one of   
Vibrio parahaemolyticus, by P. asymbiotica may contribute to its ability to infect humans [23]. 
Table 1. Type I secretion system components identified in the genome of P. luminescens. 
The percentage of identity was acquired by BLAST search against known system 
components; in parenthesis, the organism and the corresponding protein with the highest 
percentage of identity are provided.  
Component
s 
NCBI 
Accession 
Number 
Number 
of amino 
acids 
Gene locus on  
P. luminescens 
chromosome 
Identity (%)  Function/Structure 
ABC 1  NP_927979  711 aa  726,383–728,518 
57% (Bordetella 
pertussis CyaB) 
Hypothetical protein similar 
to toxin secretion ATP-
binding protein 
MFP 1  NP_927980  471 aa  728,660–730,075 
36% (Bordetella 
pertussis CyaD) 
Hypothetical protein similar 
to hemolysin export system 
MFP HlyD of E. coli 
ABC 2  NP_930357  706 aa  3,664,486–3,666,606 
46.4% (Bordetella 
pertussis CyaB) 
Hypothetical protein similar 
to toxin secretion transporter 
 NP_930359  719  aa  3,667,994–3,670,153 
44.4% (Bordetella 
pertussis CyaB) 
Hypothetical protein similar 
to toxin secretion transporter 
MFP 2  NP_93058  462 aa  3,666,606–3,667,994 
36% (Bordetella 
pertussis CyaD) 
Hypothetical protein similar 
to toxin secretion transporter 
(MFP) 
ABC 3  NP_928641  716 aa  1,546,913–1,549,063 
42.3% (Escherichia 
coli HlyB) 
Hypothetical protein similar 
to unknown protein VC1446 
of V. cholerae, probable 
RTX toxin ABC transporter 
protein 
 NP_928643  701  aa  1,550,414–1,552,519 
41.8% (Escherichia 
coli HlyB) 
RtxB (ABC transporter) 
MFP 3  NP_928642  451 aa  1,549,066–1,550,421 
32.8% (Escherichia 
coli HlyD) 
RTX toxin ABC transporter 
protein (MFP) RtxD 
ABC 4  NP_928002  576 aa  754,786–756,516 
70.4% (Serratia 
marcescens LipB) 
ATP-binding protein PrtB 
MFP 4  NP_928003  444 aa  756,577–757,911 
62.7% (Serratia 
marcescens LipC) 
MFP PrtC 
TolC 1  NP_931154  457 aa  4,641,003–4,642,376 
64.7% (Escherichia 
coli TolC) 
Outer mebrane channel 
protein 
TolC 2  NP_928004  458 aa  757,911–759,287 
50.4% (Serratia 
marcescens LipD) 
Outer membrane protein 
TolC 3  NP_929881  492 aa  3,099,833–3,101,311 
18.9% (Serratia 
marcescens LipD) 
Hypothetical protein similar 
to outer membrane factor of 
ABC transport system Toxins 2010, 2                        
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3.1.3. Type IV Secretion System 
Type IV secretion system is used by either Gram-positive or Gram-negative bacteria for the 
translocation of macromolecules across the cell envelope [40,41]. It shares an ancestral relationship to 
conjugation machines [40–43]. 
There are three different type IV secretion systems according to their effectors and have been 
identified in many bacteria including Agrobacterium tumefaciens (VirB/D4) Bordetella pertussis (Ptl), 
Helicobacter pylori (Cag) and Legionella pneumophila (Dot/Icm) [40,41,43,44]. 
The best characterized type IV system is the VirB/D4 of A. tumefaciens, thus it serves as a 
prototype for the system [41,44]. In P. luminescens, bioinformatics analysis against known type IV 
components (A. tumefaciens-Vir, B. pertussis-Ptl and L. pneumophila-Dot/Icm) failed to recognize any 
type IV secretion system homologues. 
3.1.4. Type VI Secretion System 
Type VI secretion system is a newly identified system. The type VI secretion system gene clusters 
were found to have an IcmF homologue (IcmF-associated homologue protein-IAHP), therefore 
justifies the early naming of the system as type IVB secretion system (IcmF is part of the type IV 
secretion system of Legionella pneumophila) [45,46]. 
Type VI secretion systems have been identified in Edwardsiella tarda, Burkholderia mallei, 
Pseudomonas aeruginosa and Vibrio cholerae [46–49]. This mechanism does not require N-terminal 
signal sequences [48] and it is tightly regulated at both transcriptional and post-translational   
levels [45,48]. Partially characterized components of the type VI secretion system, apart from the IcmF 
homologue, include an ATPase and a regulatory FHA domain protein (FHA = forkhead associated 
domain found in protein kinases and transcription factors) [45,46]. Generally, the type VI system gene 
clusters encode for 12-25 proteins and the effector proteins belong to either the Hcp protein family or 
the VgrG protein family [47,48]. Serine and threonine kinases and phosophatases also participate in 
the system as amino acid phosphorylation seems to play an important role. The genes encoding for 
these enzymes are usually located close to the gene encoding for the IcmF-like proteins [46]. 
In P. luminescens, multiple copies of putative type VI secretion systems were identified, most of 
which include an ATPase with the characteristic Walker A and Walker B motifs and an IcmF-like 
protein (Supplementary Table 1). 
3.2. Two Step Secretion Systems 
3.2.1. IM Translocation 
The IM translocation is mediated by the Sec translocase and/or Twin-arginine translocation (Tat) 
pathway. The Sec translocase comprises of the SecA, an ATPase, the SecYEG complex, which 
provides the pore-forming channel throughout the OM and the accessory proteins SecDF, YajC and 
YidC. SecB serves as a molecular chaperone that brings the preprotein into the Sec translocase [50].  
The Tat pathway mediates the secretion of folded [51] proteins in contrast to the Sec pathway that 
secretes unfolded proteins. Its substrate precursors have the characteristic sequence motif of two Toxins 2010, 2                        
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sequential arginine residues in their signal peptide sequence [52]. The Tat translocase of E. coli is 
comprised of TatA, TatB, TatC and TatE. In the same operon, there is an additional gene, tatD that 
encodes a DNase irrelevant to the Tat pathway [51–53].  
In P. luminescens, all components of the Sec translocase and the SecB chaperone, as well as all 
components of the Tat apparatus and two TatD putative DNase genes are identified. The components 
found present a high identity to the Sec translocase and the Tat system of E. coli (Supplementary  
Table 2). 
3.2.2. OM Translocation 
3.2.2.1. Type II Secretion System 
The type II secretion system is a two-step pathway that utilizes the Sec or Tat machinery for the 
translocation of the precursor polypeptide across the IM. In the periplasm, the polypeptide becomes 
the target of the Gsp (general secretory pathway) machinery. The Gsp machinery is normally 
comprised of 12–16 components, named by the letters A–O and S and organized into a large   
operon [54,55]. 
The OM complex is comprised of a secretin, GspD that is thought to act as the pore of the 
apparatus. Another protein, called GspS, is a lipoprotein that facilitates the insertion of the secretin 
into the OM and protects it from proteolytic degradation. GspE is a putative ATP binding protein that 
bares a Walker A motif and a putative Walker B motif. Proteins GspE, GspF, GspL and GspM interact 
to create an IM platform. GspM has also been proven to be essential for the stabilization of GspL. 
GspC and GspN are connecting components, while GspA and GspB form a complex that transfers 
energy from ATP hydrolysis [56]. 
In P. luminescens, several but not all of the components of the type II secretion apparatus were 
identified, while more than one of the components were identified on the same gene locus on the 
chromosome of the bacterium (Supplementary Table 2). 
3.2.2.2. Type V Secretion System (Autotransporter Secretion System) 
The type V or autotransporter secretion mechanism is one of the simplest and most widespread of 
all the secretion pathways. Autotransporter polypeptides are large virulent proteins, usually over   
100 kDa in size that can mediate their own secretion to the extracellular space. Autotransporter 
proteins can function as proteases, adhesins, toxins and mucinases that aid Gram-negative bacteria  
in pathogenesis. 
Autotransporters are synthesized as large multi-domain precursors comprised of an N-terminal 
signal sequence, a functional passenger domain and a C-terminal β-domain used for transport across 
the OM [30]. In order for an autotransporter polypeptide to be secreted it must first cross the 
membranes of the cell envelope. To accomplish this task, the N-terminal signal sequence inserts into 
the Sec translocase and transports the protein into the periplasm. Once periplasmically localized, the 
signal sequence is cleaved off leaving the passenger domain and the β-domain. The β-domain then 
inserts into the OM, forming a β barrel pore with a central hydrophilic structure. This pore then allows 
for the final translocation of the passenger domain to the extracellular environment. Toxins 2010, 2                        
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Bioinformatics analysis identified only one putative autotransporter protein in the genome of   
P. luminescens (Supplementary Table 2). 
3.2.2.3. Two-Partner Secretion (TPS) 
The two-partner secretion (TPS) system is common in gram-negative bacteria and is dedicated to 
the secretion of large virulent proteins, usually greater than 300 kDa. Proteins secreted via this system 
are separated into two different polypeptides. The secreted protein is labeled as TpsA, whereas the 
accessory translocator protein is termed TpsB. 
During secretion, TpsB forms a beta-barrel like structure in the outer membrane and allows for 
TpsA to exit the cell through this pore [57]. TpsA and TpsB both contain an N-terminal signal 
sequence that is recognized by the Sec translocase present in the IM. Once both proteins are 
transported across the IM, in a Sec-dependent manner, TpsB forms a β barrel structure by inserting its 
C-terminal domain into the OM. The remaining polypeptide is localized on the periplasmic side of the 
OM where it interacts with TpsA and mediates its translocation across it [30].  
Six pairs of putative TpsA-TpsB proteins were identified in the genome of P. luminescens, with 
high identity to the Tps systems of Serratia marcescens (Sh1) and Bordetella pertussis (Fha) 
(Supplementary Table 2). 
3.2.2.4. Chaperone-Usher Secretion (CU) 
The chaperone-usher pathway is responsible for the secretion of proteins forming rod-like 
organelles that protrude from the bacterial cell surface. These rod-like proteins are composed of 
various components of subunits. Two proteins commonly utilized by this pathway are P pili and type I 
pili. These virulent pilus structures aid pathogenic bacteria in formation of biofilms, interactions with 
hosts and evasion of host defenses [58].  
In order for pili subunits to be secreted, each individual subunit enters the periplasm via the Sec 
translocase complex. Once in the periplasm, each subunit interacts with a chaperone to form a stable 
chaperone-subunit complex. Once the chaperone-subunit complexes are formed, they associate with an 
usher present in the OM. The usher forms a ring shaped pore that allows for the addition of the pilus 
subunits in a tip-to-base polymerization. The usher facilitates this polymerization by recognizing 
chaperone-subunit complexes according to their final positions in the mature pilus structure [57,58].  
Eight possible chaperone-usher systems were identified in P. luminescens genome. Of those eight, 
three systems had chaperone-ushers with predicted signal peptides necessary for IM translocation 
(Supplementary Table 2). 
4. Conclusions  
P. luminescens is a nematode-symbiotic bacterium with a complex life cycle. As such, it needs to 
coordinate symbiosis and pathogenicity, thus the production of factors that can assist in both is 
necessary. Various toxins have been found in the genome of the bacterium, with both oral and 
injectible activities. These toxins are categorized into four groups; some of them are part of the 
pathogenicity islands identified in the P. luminescens genome. Toxins 2010, 2                        
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Tcs are encoded by PAI I and show no similarity to other known proteins; they show high oral 
activity. The Photorhabdus  insect related (Pir) toxins are binary proteins that are similar to the   
δ-endotoxins of B. thuringiensis. Mcf1 and Mcf2 are encoded by PAI II and act upon injection; these 
toxins have similarities to the C. difficile toxin, as well as RTX-like toxins. Finally, PVCs show 
homology to antifeeding genes in S. entomophila and encode proteins resembling types of bacteriocins.  
Secretion of these proteins may happen through different secretion systems. Bioinformatics analysis 
against components of all known secretion systems revealed the existence of multiple copies of 
various secretion systems components throughout the genome of the bacterium (Tables 2 and 3). 
Table 2. Summary of one-step secretion systems in P. luminescens.  
Secretion 
System 
# of putative systems identified 
Type I  6 
Type III  2 
Type IV  0 
Type VI  4 
All, but type IV secretion systems are part of the “armory” of P. luminescens for survival and 
pathogenicity. This indicates that the bacterium possesses all the necessary means for the secretion of 
virulence factors, thus it is capable to establish a microbial infection. 
Both type III and IV are used for the direct delivery of effectors in the host cell, using similar 
structures, thus assisting in processes such as immune system evasion during infection establishment [23]. 
This is important during the life cycle of the bacterium for its survival. Since both of the 
aforementioned systems could serve the same purpose, the presence of two type III secretion systems 
could counteract/justify the absence of a type IV system. On the other hand, type VI secretion systems 
(formerly known as type IVB) have also been identified; type VI secretion system is yet another 
system with similar secretion apparatus and could also justify the absence of a type IV secretion system. 
Multiple copies of other secretion systems could be attributed to the variety of toxins, virulence 
factors and other proteins necessary for survival and infestation, secreted from P. luminescens. Further 
analysis however is necessary in order to identify the exact secretion mechanisms of the known toxins, 
as well as their exact role in establishing infection. Finally, the information presented in review could 
help in the identification of new secreted toxins through the identified secretion systems. 
Table 3. Summary of two-step secretion systems in P. luminescens. 
Secretion System  # of putative systems identified 
Type II  1 
Type V  1 
TPS 6 
Chaperone-Usher 8 
 Toxins 2010, 2                        
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